Cargando…
Clinical Relevance of Liver Kinase B1(LKB1) Protein and Gene Expression in Breast Cancer
Liver kinase B1 (LKB1) is a tumor suppressor, and its loss might lead to activation of the mammalian target of rapamycin (mTOR) and tumorigenesis. This study aimed to determine the clinical relevance of LKB1 gene and protein expression in breast cancer patients. LKB1 protein expression was evaluated...
Autores principales: | Chen, I-Chun, Chang, Yuan-Ching, Lu, Yen-Shen, Chung, Kuei-Pin, Huang, Chiun-Sheng, Lu, Tzu-Pin, Kuo, Wen-Hung, Wang, Ming-Yang, Kuo, Kuan-Ting, Wu, Pei-Fang, Hsueh, Tsu-Hsin, Shen, Chen-Yang, Lin, Ching-Hung, Cheng, Ann-Lii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753425/ https://www.ncbi.nlm.nih.gov/pubmed/26877155 http://dx.doi.org/10.1038/srep21374 |
Ejemplares similares
-
High prevalence of APOA1/C3/A4/A5 alterations in luminal breast cancers among young women in East Asia
por: Lin, Ching-Hung, et al.
Publicado: (2021) -
High Prevalence of the BIM Deletion Polymorphism in Young Female Breast Cancer in an East Asian Country
por: Lin, Ching-Hung, et al.
Publicado: (2015) -
TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays
por: Lin, Ching-Hung, et al.
Publicado: (2015) -
CYP19 Genetic Polymorphism Haplotype AASA Is Associated with a Poor Prognosis in Premenopausal Women with Lymph Node-Negative, Hormone Receptor-Positive Breast Cancer
por: Kuo, Sung-Hsin, et al.
Publicado: (2013) -
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
por: Kuo, Sung-Hsin, et al.
Publicado: (2023)